LabCompass

Shelby Sloan

Medicine · The Ohio State University

Early career · publishing since 2018Rising activity

Publications

47

Citations

165

Est. group size

~25

Recurring co-author estimate

Active years

9

Publishing since 2018

Research summary
AI-generated

Shelby Sloan's research focuses on cancer biology, with recent work examining how specific signaling pathways (such as YAP/TAZ-TEAD) drive tumor stem cell behavior and tumor diversity in pediatric high-grade brain tumors (gliomas). Related work also touches on brain injury in newborns, looking at astrocyte cells (a type of brain support cell) as potential markers or treatment targets. The broader body of work spans topics like lymphoma, gene regulation in cancer, cell signaling pathways, and immune cell therapies such as CAR-T cell treatment.

Pediatric brain tumors (glioma) biologyCancer cell signaling pathwaysTumor stem cells and tumor heterogeneityPerinatal brain injury and astrocyte biologyImmune-based cancer therapies

Publication output has grown markedly, rising from a handful of papers per year in 2017-2020 to a notable surge in 2025 after a period of steady mid-single-digit annual output.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 6.8/year recently
172018: 3 publications182019: 3 publications192020: 1 publication202021: 6 publications212022: 6 publications222023: 6 publications232024: 1 publication242025: 19 publications19252026: 2 publications26
Publishes in
  • Blood×13
  • Blood Advances×3
  • PLoS ONE×2
  • Cancer Research×2
  • Experimental Hematology and Oncology×1
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile